Cargando…
Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497461/ https://www.ncbi.nlm.nih.gov/pubmed/31073370 http://dx.doi.org/10.18632/oncotarget.26870 |
| _version_ | 1783415474281775104 |
|---|---|
| author | Marmorino, Federica Falcone, Alfredo Cremolini, Chiara |
| author_facet | Marmorino, Federica Falcone, Alfredo Cremolini, Chiara |
| author_sort | Marmorino, Federica |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6497461 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64974612019-05-09 Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial Marmorino, Federica Falcone, Alfredo Cremolini, Chiara Oncotarget Editorial Impact Journals LLC 2019-04-19 /pmc/articles/PMC6497461/ /pubmed/31073370 http://dx.doi.org/10.18632/oncotarget.26870 Text en Copyright: © 2019 Marmorino et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Marmorino, Federica Falcone, Alfredo Cremolini, Chiara Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial |
| title | Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial |
| title_full | Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial |
| title_fullStr | Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial |
| title_full_unstemmed | Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial |
| title_short | Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial |
| title_sort | bevacizumab as maintenance therapy in mcrc: interpreting results of the moma trial |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497461/ https://www.ncbi.nlm.nih.gov/pubmed/31073370 http://dx.doi.org/10.18632/oncotarget.26870 |
| work_keys_str_mv | AT marmorinofederica bevacizumabasmaintenancetherapyinmcrcinterpretingresultsofthemomatrial AT falconealfredo bevacizumabasmaintenancetherapyinmcrcinterpretingresultsofthemomatrial AT cremolinichiara bevacizumabasmaintenancetherapyinmcrcinterpretingresultsofthemomatrial |